| Lim, Riwat (Curetis 2017Q3– Managing Director of Curetis UK Ltd + Commercial Director EMEA before Qiagen) |
Managing Director |
Curetis (Group) |
United Kingdom (GB) |
| Lim, Seung-Hak (Daniel) (Seegene 201304 Head Overseas Business division) |
President/Director/Head Business Group/Unit/Division |
Seegene (Group) |
Korea, Republic of |
| Lim, Sun Hee (AllMedica 201305 General Manager, Biosensor Research Group) |
General Manager (management) |
AllMedicus Co., Ltd. |
Korea, Republic of |
| Limmer, Christian (Constares GmbH 202001 Managing Director) |
n. a. |
Constares GmbH |
Germany |
| Limmer, Stefan (Ribopharma) |
n. a. |
LGC (Group) |
Germany |
| Lin, He (Shanghai Jiao Tong Univ 201203 Professor + Director of Bio-X Center) |
Professor |
Shanghai Jiao Tong University (SJTU) |
China |
| Lin, Raven (I-Mab 201711 Head of Business Development at I-Mab Biopharma) |
Business Development Manager / Strategy Manager |
I-Mab (Group) |
China |
| Linari, Marco (Merck (DE) 201409 CEO Allergopharma/Merck Business Unit Allergy) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Lindauer, Andreas (Synlab 200702) |
n. a. |
Synlab (Group) |
Germany |
| Lindemann, Björn F. |
n. a. |
BioAgency AG |
Germany |
| Lindemann, Erik P. (BioAgency 201102 CEO) |
Chief Executive Officer (CEO) |
BioAgency AG |
Germany |
| Lindemann, Michael (bio.logis 2009– Managing Director before IBM before Siemens Medical before Genedata) |
Managing Director |
Genedata (Group) |
Switzerland |
| Lindemann, Timo (Sartorius 201906 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Lindemeier, Jürgen (Xiril 201007 CEO) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
| Linden, H. Bernhard (Linden CMS 1979–200910– Managing Director + Founder) |
Managing Director |
Linden ChroMasSpec GmbH (Linden CMS) |
Germany |
| Lindenblatt, Hubert (Odgers Berndtson Unternehmensberatung GmbH 201203 Partner) |
Consultant (economic/technology) |
Odgers Berndtson Unternehmensberatung GmbH |
Germany |
| Lindenblatt, Jörg (Sartorius 201410 SVP Sales Asia/Pacific) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Lindhofer, Horst (Lindis Pharma 201004– CEO + Founder before Trion Pharma CEO + Founder) |
Chief Executive Officer (CEO) |
Lindis Biotech GmbH |
Germany |
| Lindhorst, Thomas (UgiSense 201604– Exec Board Director + Ugichem 201108 Managing Director CSO + founder) |
Managing Director |
UgiSense AG |
Germany |
| Lindhuber, Matthias (Bruker 201703 Bruker AXS GmbH) |
n. a. |
Bruker Corporation (Group) |
Germany |
| Linding, Rune (Institute of Cancer Research 200907 Head Cellular and Molecular Logic Team) |
Researcher (university / research institute) |
University of London |
United Kingdom (GB) |
| Lindinger, Werner (1998–2001+ Prof Univ Innsbruck + CEO + Co-founder Ionicon Analytik GmbH) |
Chief Executive Officer (CEO) |
Ionicon (Group) |
Austria |
| Lindner, Wolfgang (Univ Vienna 201402 Professor Emeritus Analytical Chemistry) |
Professor |
University of Vienna (Universität Wien) |
Austria |
| Lindpaintner, Klaus (Thermo Fisher 201211– CSO before Strategic Diagnostics + Roche) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Thermo Fisher (Group) |
United States (USA) |
| Lingelbach, Dieter (Sirion Biotech 201305 Managing Director (COO) before MorphoSys –200812c Head AbD Serotec) |
Managing Director |
Bio-Rad (Group) |
Germany |
| Lingelbach, Thomas (Intercell 201106– CEO before COO before 2001– Chiron Behring) |
Chief Executive Officer (CEO) |
Valneva (Group) |
Austria |
| Lingnau, Lutz (Schering) |
n. a. |
Bayer (Group) |
Germany |
| Link, Charles J., jr. (NewLink Genetics 201706 CEO) |
Chief Executive Officer (CEO) |
NewLink Genetics Corporation (Nasdaq: NLNK) |
United States (USA) |
| Link, Dieter (Max Planck 201104 License Manager at Max Planck Innovation) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Link, Egenhard (Garching Innovation 200311) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Link, Markus (Bruker 201503) |
n. a. |
Bruker Corporation (Group) |
Germany |
| Linnartz, Anke (MorphoSys 201611– Head Corp Communications + IR before Gerresheimer + Demag Cranrd + GEA + MIS) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Linneberg, Esther (Sividon Diagnsotics GmbH 201202) |
n. a. |
Myriad Genetics (Group) |
Germany |
| Linnert, Karoline (Bremen (govt) 201308 Major) |
n. a. |
Bremen (govt region) |
Germany |
| Linnertz, Holger (Mettler-Toledo 200712 Head LabX Competence Center) |
Product Manager (personnel) |
Mettler-Toledo (Group) |
Switzerland |
| Linscheid, Michael W. (Humboldt Univ Berlin 1009 Professor) |
n. a. |
Humboldt University Berlin |
Germany |
| Linseis, Brigitte (Bavaria (govt) 201402 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Linsinger, Thomas (EU (govt) 201605 JRC-IRMM Responsible CRM Distriubtion/Scientific Officer) |
n. a. |
EU (govt) |
Belgium |
| Linssen, Marcel (Wilex 201309 CBO at Heidelberg Pharma GmbH) |
Chief Business Officer (CBO) |
Heidelberg Pharma (Group) |
Germany |
| Linton, William A. (Bill) (Promega 1978– CEO + Founder and Eppendorf 201701– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Promega (Group) |
United States (USA) |
| Linz, Fritjof (Sartorius 201903 Head of Separation at SSB) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Linzbach, Gerold (Symrase 200804 CEO) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Germany |
| Lippold, Björn (Chemie.de 201403 Senior Editor) |
Editor / Publisher |
Lumitos (Group) |
Germany |
| Lippold, Marcus ([iito] Business Intelligence 2002–) |
Company Founder |
[iito] Business Intelligence |
Germany |
| Lipps, Ben (MagForce 201411 CEO) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
| Lipscombe, Richard (Proteomics International 201201 Managing Director) |
Managing Director |
Proteomics International Pty Ltd. |
Australia |
| Litchman, Manuel (Arvinas 201711 CEO) |
Chief Executive Officer (CEO) |
Arvinas (Group) |
United States (USA) |
| Litow, Micah (Danaher 201405 Director Reserarch + Innovation Advanced Staining Instruments at Leica Biosystems) |
n. a. |
Danaher (Group) |
Germany |
| Little, Melvyn (Affimed 2000–201112 CSO + founder retired 12/11 before DKFZ) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Affimed (Group) |
Germany |
| Little, Stephen (Premaitha Health 201512 CEO before Qiagen + DxS) |
Chief Executive Officer (CEO) |
Premaitha Health (Group) |
United Kingdom (GB) |
| Little, Tod (Taconic 201309 CEO) |
Chief Executive Officer (CEO) |
Taconic (Group) |
United States (USA) |
| Litzka, Olivier (LCF Rothschild 2006–200911– Partner EdRIP before 3i Venture Healthcare) |
Partner (venture partner) |
Andera Partners (FR) |
France |
| Liu, Cheng (Eureka Therapeutics 201505 CEO) |
Chief Executive Officer (CEO) |
Eureka Therapeutics Inc. |
United States (USA) |
| Liu, Douglas (Qiagen 200507–201710c VP Global Operations before Bayer Healthcare RETIRED 2017) |
n. a. |
Qiagen (Group) |
Netherlands |
| Liu, Jack (OmicSoft Corp 201701 President + Co-Founder) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
| Llewellyn, Chris (Schauenburg 201912 Asia Pacific Sales Manager at Markes 201406 Global Channel Manager) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Llobet, Manuel (Allergy Therapeutics 201709 CEO) |
Chief Executive Officer (CEO) |
Allergy Therapeutics (Group) |
United Kingdom (GB) |
| Lloyd-Harris, Genghis (Abingworth 201402 Partner) |
Partner (venture partner) |
Abingworth (Group) |
United Kingdom (GB) |
| Lo, Richard (Techcomp 201411 CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
China |
| Loa, Alexander (acCELLerate GmbH 201605 Managing Director) |
Managing Director |
Accellerate GmbH |
Germany |
| Lobacki, Joseph (Micromet 201112– COO before Genzyme SVP + General Manager before SangStat Medical + Cell Pathways) |
Chief Operating Officer (COO) |
Amgen (Group) |
United States (USA) |
| Lochter, André (atugen 2003– before Nordic Bioscience) |
n. a. |
Silence Therapeutics (Group) |
Germany |
| Locker, Susanne (LISAvienna 201310 Project Manager Marketing + PR) |
Sales Manager / Marketing Manager |
Austria (govt) |
Austria |
| Lockhoff, Oswald (Sidanis Pharma 201102– Managing Director + Founder before Consultant before Bayer) |
Managing Director |
Sidanis Pharma GmbH |
Germany |
| Loeb, Gary H. (Sangamo 201907– EVP + General Counsel before Achaogen + Amyris + Genentech) |
General Counsel / Chief Legal Officer (CLO) |
Sangamo (Group) |
United States (USA) |
| Loehr, Achim (CureVac 201710 Head Business Development) |
Business Development Manager / Strategy Manager |
CureVac (Group) |
Germany |
| Loescher, Peter (Siemens 200705– CEO before Merck & Co) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Loew-Friedrich, Iris (UCB 201403 CMO before Schwarz Pharma) |
Chief Medical Officer (CMO) |
UCB (Group) |
Belgium |
| Lofton-Day, Catherine (Epigenomics 200607 VP Molecular Biology, Diagnostics) |
n. a. |
Epigenomics (Group) |
Germany |
| Lohfink, Martin (up to data 201003 Managing Director) |
Managing Director |
up to data professional services GmbH |
Germany |
| Lohmann, Charlotte (MorphoSys 201205– General Counsel before Wilex SVP Legal Affairs + Human Resources before KPMG) |
General Counsel / Chief Legal Officer (CLO) |
MorphoSys (Group) |
Germany |
| Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Germany |
| Lohmer, Stefan (Axxam 200807 CEO) |
Chief Executive Officer (CEO) |
Axxam S.p.A. |
Italy |
| Lohrisch, Hans-Joachim (Altana Pharma 200607 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Germany |
| Lohse, Axel (Germany (govt) 201611 Manager Biotech + Pharma at GTAI) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Loibner, Hans (Apeiron Biologics 200810–201807 CEO RETIRED 7/18 continues as senior advisor) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Loiret-Bernal, Cédric (GeneProt 200009 CEO) |
Chief Executive Officer (CEO) |
GeneProt Inc. |
Switzerland |
| Longchamp, Pascal (Evolva 201201–201712 CBO TO STEP DOWN unitl end 2017) |
Chief Business Officer (CBO) |
Evolva (Group) |
Switzerland |
| Looi, Liew Yew (Nycomed 201011 SVP North Asia) |
Regional manager |
Takeda (Group) |
Switzerland |
| Loose, Achim (Nordantec GmbH 200902 Managing Director) |
Managing Director |
Nordantec GmbH Norddeutsche Analytik und Messtechnik |
Germany |
| Lopata, Michael (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
| Lopez Belda, Antonio (Biofrontera 201503– Marketing Manager at Biofrontera Spain before Allergan Pharmaceuticals) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Spain (España) |
| Lopriore, Stefano (STMicroelectronics 200506) |
n. a. |
STMicroelectronics (Group) |
Switzerland |
| Lorenz, Fabian (MC Services 201504– Senior Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Lorenz, Martin (Platomics 201908 Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Platomics GmbH |
Austria |
| Lorenz, Michael (Univ Bremen + Molzym) |
Managing Director |
Kompass (Group) |
Germany |
| Los, Georgyi (Leica 200808 Lead Scientist Imaging Products) |
n. a. |
Danaher (Group) |
Germany |
| Loss, Christian (Neopharm 201502 Managing Director of Neovii Biotech GmbH) |
Managing Director |
Neopharm (IL) (Group) |
Germany |
| Lossau, Harald |
n. a. |
FRIZ Biochem GmbH |
Germany |
| Lottspeich, Friedrich (MPI 1993) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) |
Chief Executive Officer (CEO) |
ObsEva (Group) |
Switzerland |
| Love, Doug (Annexon Biosciences 201812 CEO) |
Chief Executive Officer (CEO) |
Annexon Biosciences Inc. |
United States (USA) |
| Loven, Jakob (Nextech Invest 201904 Partner) |
Partner (venture partner) |
Nextech (Group) |
Switzerland |
| Loveridge, Jason (4SC 201609– CEO) |
Chief Executive Officer (CEO) |
4SC (Group) |
Germany |
| Lowenstein, Inese (Danaher 201709– President at Sciex joined 8/16 before Merck KGaA) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Lowinger, Timothy B. (Mersana Therapeutics 201406 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mersana Therapeutics Inc. (Nasdaq: MRSN) |
United States (USA) |
| Loy, André (Stratec 201107 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Stratec (Group) |
Germany |
| Lubenau, Heinz (Vaximm 201101 Managing Director Vaximm GmbH before BioGeneriX before Servier) |
Managing Director |
Vaximm (Group) |
Germany |
| Lubenow, Helge (Qiagen 201207– promoted SVP Molecular Diagnostics at Qiagen since 1997 before VP MDx Marketing) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
1 2 3 ... 35 36 37 ... 68 69 70 
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
